Fumaric acid esters as a suitable first-line treatment for severe psoriasis: An Irish experience

Clinical and Experimental Dermatology

Volumn 37, Issue 7, 2012, Pages 793-795

  Heelan, K ^a   Markham, T ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ETRETIN; FUMADERM; METHOTREXATE;

ABDOMINAL CRAMP; ADULT; AGED; BLURRED VISION; CLINICAL ARTICLE; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; EOSINOPHILIA; FEMALE; HOT FLUSH; HUMAN; LETTER; LYMPHOCYTOPENIA; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; ULTRAVIOLET B RADIATION;

ADULT; AGED; DERMATOLOGIC AGENTS; ESTERS; FEMALE; FUMARATES; HUMANS; IRELAND; MALE; MIDDLE AGED; PSORIASIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84866735742     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2012.04351.x     Document Type: Letter

References (5)

1. Wain E, Darling M, Pleass R, et al. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study. Br J Dermatol 2010; 162: 427-34.
2. Reich K, Thaci D, Mrowietz U, et al. Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis-a retrospective study (FUTURE). JDDG 2009; 7: 603-11.
3. Fallah Arani S, Neumann H, Hop WCJ, Thio HB,. Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled trial. Br J Dermatol 2011; 164: 855-61.
4. Nast A, Kopp IB, Augustin M, et al. S3-Leitlinie zur Therapie der Psoriasis vulgaris. J Dtsch Dermatol Ges 2006; 4: S1-126.
5. Fika Z, Williams R, Williamson D,. Fumaric acid esters in psoriasis. Br J Dermatol 2006; 154: 567-8.